Pathogen inactivation technologies and quality of platelet concentrates (Review of literature)
- Authors: Ignatova A.A.1, Trakhtman P.E.1, Panteleev M.A.1
-
Affiliations:
- Federal Research Center of Pediatric Hematology, Oncology and Immunology named after Dmitry Rogachev, Ministry of Health of the Russian Federation
- Issue: Vol 15, No 2 (2016)
- Pages: 27-31
- Section: Статьи
- Submitted: 19.09.2018
- Published: 19.06.2016
- URL: https://hemoncim.com/jour/article/view/158
- DOI: https://doi.org/10.24287/1726-1708-2016-15-2-27-31
- ID: 158
Cite item
Full Text
Abstract
Platelet concentrate (PC) transfusion is practically the only fast and universal way of correcting platelet function in a broad range of clinical situations in paediatric haematology. Due to a short storage time of PC, technologies of pathogen inactivation are very important for decreasing the risks of immune responses and infections. There are numerous studies indicating that platelet function can change in pathogen inactivation. The article offers a literature review of laboratory and clinical studies aimed at assessment of the significance and direction of these changes, and also discusses practical implications of such studies for clinical work with PC.
About the authors
Anastasia A. Ignatova
Federal Research Center of Pediatric Hematology, Oncology and Immunology named after Dmitry Rogachev, Ministry of Health of the Russian Federation
Author for correspondence.
Email: procyonnlotor@gmail.com
Russian Federation
Pavel E. Trakhtman
Federal Research Center of Pediatric Hematology, Oncology and Immunology named after Dmitry Rogachev, Ministry of Health of the Russian Federation
Email: trakhtman@mail.ru
Russian Federation
Mikhail A. Panteleev
Federal Research Center of Pediatric Hematology, Oncology and Immunology named after Dmitry Rogachev, Ministry of Health of the Russian Federation
Email: mapanteleev@yandex.ru
Russian Federation
References
Supplementary files
